<![CDATA[Amylyx Pharmaceuticals, Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=44176>Mon, 04 May 2026 05:11:34 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European Union Following Re-Examination Process]]>https://www.newswire.co.kr/newsRead.php?no=976291Sun, 15 Oct 2023 11:32:07 +0900